|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.775
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.513
|
Human |
|
|
anion transport
|
GO:0006820 |
177 |
0.482
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.479
|
|
|
|
organophosphate ester transport
|
GO:0015748 |
28 |
0.473
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.425
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.402
|
Human |
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.379
|
Human |
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.377
|
Human |
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.367
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.342
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.312
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.312
|
|
|
|
short chain fatty acid catabolic process
|
GO:0019626 |
2 |
0.304
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.300
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.288
|
Human |
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.285
|
Human |
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.280
|
Human |
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.277
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.276
|
Human |
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.265
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.265
|
Human |
|
|
phospholipid transport
|
GO:0015914 |
21 |
0.254
|
|
|
|
intestinal cholesterol absorption
|
GO:0030299 |
5 |
0.252
|
Human |
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.247
|
Human |
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.245
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.244
|
Human |
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.242
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.239
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.237
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.225
|
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.216
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.216
|
Human |
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.201
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.200
|
Human |
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.193
|
Human |
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.191
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.186
|
Human |
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.185
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.185
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.184
|
Human |
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.184
|
Human |
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.180
|
Human |
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.176
|
Human |
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.175
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.170
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.169
|
Human |
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.168
|
Human |
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.168
|
Human |
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.166
|
Human |
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.164
|
Human |
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.161
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.157
|
Human |
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.152
|
Human |
|
|
cation transport
|
GO:0006812 |
399 |
0.152
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.147
|
Human |
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.146
|
Human |
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.145
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.142
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.133
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.133
|
Human |
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.128
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.127
|
Human |
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.127
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.126
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.125
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.122
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.122
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.118
|
Human |
|
|
gland development
|
GO:0048732 |
330 |
0.116
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.116
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.115
|
Human |
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.113
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.112
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.109
|
Human |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.106
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.106
|
Human |
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.105
|
Human |
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.105
|
Human |
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.104
|
Human |
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.098
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.094
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.094
|
Human |
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.093
|
Human |
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.091
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.090
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.086
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.086
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.084
|
Human |
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.083
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.083
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.083
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.080
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.078
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.078
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.077
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.075
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.075
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.074
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.073
|
Human |
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.072
|
Human |
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.069
|
Human |
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.069
|
Human |
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.068
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.064
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.064
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.064
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.064
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.063
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.063
|
Human |
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.062
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.062
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.062
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.061
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.060
|
Human |
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.059
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.059
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.059
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.059
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.058
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.058
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.057
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.057
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.056
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.056
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.056
|
Human |
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.056
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.055
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.055
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.054
|
Human |
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.054
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.054
|
|
|
|
drug transmembrane transport
|
GO:0006855 |
5 |
0.053
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.052
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.052
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.051
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
25 |
0.051
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.049
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.049
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.048
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.047
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.047
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.047
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.046
|
Human |
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.046
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.046
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.045
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.045
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.045
|
Human |
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.045
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.044
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.044
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.044
|
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.043
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.043
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.043
|
|
|
|
regulation of cholesterol transport
|
GO:0032374 |
17 |
0.042
|
Human |
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.042
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.042
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.042
|
Human |
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.041
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
4 |
0.041
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.041
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.041
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.041
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.040
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.040
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.040
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.039
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.038
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.038
|
|
|
|
regulation of digestive system process
|
GO:0044058 |
13 |
0.038
|
Human |
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.038
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.038
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.037
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.037
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.037
|
|
|
|
lipid digestion
|
GO:0044241 |
7 |
0.036
|
Human |
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.036
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.035
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.035
|
Human |
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.035
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.035
|
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
1 |
0.035
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.034
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.034
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.034
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.033
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.033
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.033
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.033
|
Human |
|
|
epidermis development
|
GO:0008544 |
187 |
0.033
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.033
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.033
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.032
|
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.032
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.032
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.032
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.032
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.032
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.031
|
|
|
|
regulation of cholesterol biosynthetic process
|
GO:0045540 |
8 |
0.031
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.031
|
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.031
|
Human |
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.031
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.031
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.031
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.031
|
|
|
|
drug transport
|
GO:0015893 |
7 |
0.031
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.031
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.031
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.030
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.030
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.030
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.030
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.030
|
|
|
|
steroid esterification
|
GO:0034433 |
3 |
0.030
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.030
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.029
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.029
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.029
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.029
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.029
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.029
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.029
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.029
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.029
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.029
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.028
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.028
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.028
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.028
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.028
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.028
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.028
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.028
|
|
|
|
male genitalia morphogenesis
|
GO:0048808 |
4 |
0.028
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.028
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.028
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.027
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.027
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.027
|
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.027
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.027
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.027
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.027
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.027
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.027
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.027
|
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.026
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.026
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.026
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.026
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.026
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.026
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.026
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.026
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.026
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.025
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.025
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.025
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.025
|
|
|
|
exogenous drug catabolic process
|
GO:0042738 |
1 |
0.025
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.025
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.025
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.025
|
|
|
|
cellular phosphate ion homeostasis
|
GO:0030643 |
2 |
0.025
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.025
|
Human |
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.024
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.024
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.024
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.024
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.024
|
Human |
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.024
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.024
|
|
|
|
protein oxidation
|
GO:0018158 |
2 |
0.024
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.024
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.024
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.023
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.023
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.023
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.023
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.023
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.023
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.023
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.023
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.023
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.023
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.023
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.022
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.022
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.022
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.022
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.022
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.022
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.022
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.022
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.022
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.022
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.022
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.021
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.021
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.021
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.021
|
|
|
|
naphthalene metabolic process
|
GO:0018931 |
1 |
0.021
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.021
|
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
29 |
0.021
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.021
|
|
|
|
vacuole organization
|
GO:0007033 |
38 |
0.021
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.021
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.021
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.020
|
|
|
|
eating behavior
|
GO:0042755 |
15 |
0.020
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.020
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.020
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.020
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.020
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.020
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.020
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.020
|
|
|
|
lysosome organization
|
GO:0007040 |
21 |
0.020
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.020
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.020
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.020
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.020
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.019
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.019
|
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.019
|
|
|
|
acylglycerol homeostasis
|
GO:0055090 |
16 |
0.019
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.019
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.019
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.019
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.019
|
|
|
|
positive regulation of steroid biosynthetic process
|
GO:0010893 |
4 |
0.019
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.019
|
|
|
|
response to defense related host nitric oxide production
|
GO:0052565 |
2 |
0.019
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.019
|
|
|
|
triglyceride mobilization
|
GO:0006642 |
5 |
0.019
|
|
|
|
regulation of acetylcholine secretion neurotransmission
|
GO:0014056 |
2 |
0.019
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.019
|
|
|
|
xenobiotic transport
|
GO:0042908 |
1 |
0.018
|
|
|
|
negative regulation of digestive system process
|
GO:0060457 |
5 |
0.018
|
Human |
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.018
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.018
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.018
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.018
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.018
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.018
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.018
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.018
|
|
|
|
excretion
|
GO:0007588 |
22 |
0.017
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.017
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.017
|
|
|
|
positive regulation of dopamine secretion
|
GO:0033603 |
2 |
0.017
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.017
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.017
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.017
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.017
|
|
|
|
regulation of glutamate secretion
|
GO:0014048 |
3 |
0.017
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.017
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.017
|
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.017
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.017
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.017
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.017
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.017
|
|
|
|
adipose tissue development
|
GO:0060612 |
25 |
0.017
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.017
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.017
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.017
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.017
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.016
|
|
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.016
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.016
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.016
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.016
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.016
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.016
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.016
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.016
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.016
|
|
|
|
response to bacterial lipoprotein
|
GO:0032493 |
4 |
0.016
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.016
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.016
|
|
|
|
positive regulation of glutamate secretion
|
GO:0014049 |
2 |
0.016
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.016
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.016
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.016
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.016
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.016
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.016
|
Human |
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.016
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.016
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.016
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.016
|
|
|
|
memory
|
GO:0007613 |
58 |
0.016
|
|
|
|
detection of molecule of bacterial origin
|
GO:0032490 |
2 |
0.015
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.015
|
|
|
|
regulation of phospholipid transport
|
GO:2001138 |
4 |
0.015
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.015
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.015
|
|
|
|
oxidative demethylation
|
GO:0070989 |
1 |
0.015
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.015
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.015
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.015
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.015
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.015
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.015
|
|
|
|
positive regulation of phospholipid translocation
|
GO:0061092 |
2 |
0.015
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.015
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
2 |
0.015
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.015
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.015
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.015
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.015
|
|
|
|
diterpenoid biosynthetic process
|
GO:0016102 |
7 |
0.014
|
|
|
|
positive regulation of beta amyloid clearance
|
GO:1900223 |
1 |
0.014
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.014
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.014
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.014
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.014
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.014
|
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.014
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.014
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.014
|
|
|
|
negative regulation of lipid transport
|
GO:0032369 |
8 |
0.014
|
Human |
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.014
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.014
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.014
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.014
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.014
|
|
|
|
positive regulation of catecholamine secretion
|
GO:0033605 |
2 |
0.014
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.014
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.014
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.014
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.014
|
|
|
|
organic hydroxy compound catabolic process
|
GO:1901616 |
25 |
0.014
|
|
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.014
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.014
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.014
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.014
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.014
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.014
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.014
|
|
|
|
toxin transport
|
GO:1901998 |
38 |
0.013
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.013
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.013
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.013
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.013
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.013
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.013
|
|
|
|
regulation of vascular endothelial growth factor production
|
GO:0010574 |
13 |
0.013
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.013
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.013
|
|
|
|
low density lipoprotein particle remodeling
|
GO:0034374 |
2 |
0.013
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.013
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.013
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.013
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.013
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.013
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.013
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.013
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.013
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.013
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.013
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.013
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.013
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.013
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.013
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.013
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.013
|
|
|
|
generation of ovulation cycle rhythm
|
GO:0060112 |
1 |
0.013
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.012
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.012
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.012
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.012
|
|
|
|
interleukin 17 production
|
GO:0032620 |
11 |
0.012
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.012
|
|
|
|
negative regulation of myeloid leukocyte differentiation
|
GO:0002762 |
20 |
0.012
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.012
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.012
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.012
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.012
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.012
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.012
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.012
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.012
|
|
|
|
type ii pneumocyte differentiation
|
GO:0060510 |
7 |
0.012
|
|
